BACKGROUND AND PURPOSE: The development of new MR imaging scanners with
stronger gradients and improvement in coil technology, allied with emerging fast imaging …

Abstract Background and Purpose High‐resolution three‐dimensional (3D) post‐contrast
imaging of the brain is essential for comprehensive evaluation of inflammatory, neoplastic …

BACKGROUND AND PURPOSE: In multiple sclerosis, gadolinium enhancement is used to
classify lesions as active. Regarding the need for a standardized and accurate method for …

Purpose To determine if contrast‐enhanced (CE) MRI of intracranial lesions benefits from
time‐resolved MR angiography (MRA) during contrast agent injection. Materials and …

MR imaging without and with gadolinium-based contrast agents (GBCAs) is an important
imaging tool for defining normal anatomy and characteristics of lesions. GBCAs have been …

Gadopentetate dimeglumine is presently the only MR contrast agent approved by the FDA
for MR imaging of the brain and spine. The current recommended dose is 0. i mmol/kg, and …

Advanced MR imaging techniques have become an integral part of the evaluation of
patients with brain tumors. Although structural imaging provides the primary foundation of an …

A retrospective analysis of intracranial magnetic resonance (MR scans of 514 patients who
underwent nonselective Gd-DTPA enhanced MR imaging was performed to determine the …

Since their introduction, gadolinium-based contrast media are routinely used in most CNS
MR imaging indications. Due to their paramagnetic effect, they significantly shorten the T1 …

PURPOSE To determine whether the method of delivery of gadolinium can alter optimal
small-vessel detail in MR angiography. METHODS Six healthy volunteers were studied with …